# Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

> **NCT00948493** · — · NO_LONGER_AVAILABLE · sponsor: **Generex Biotechnology Corp.**

## Conditions studied

- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Buccal insulin spray

## Key facts

- **NCT ID:** NCT00948493
- **Lead sponsor:** Generex Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948493, "Treatment Use of Generex Oral-lyn™ in Patients With Diabetes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00948493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*